Safety, pharmacokinetics and dose-response characteristics of GSK2269557, an inhaled PI3Kδ inhibitor under development for the treatment of COPD
Cahn, A., Hamblin, J.N., Begg, M., Wilson, R., Dunsire, L., Sriskantharajah, S., Montembault, M., Leemereise, C.N., Galinanes-Garcia, L., Watz, H., Kirsten, A.M., Fuhr, R., Hessel, E.M.
Published in Pulmonary pharmacology & therapeutics (01.10.2017)
Published in Pulmonary pharmacology & therapeutics (01.10.2017)
Get full text
Journal Article
A33 CLINICAL STUDIES IN OBSTRUCTIVE LUNG DISEASE: Safety, Pharmacokinetics And Dose-Response Characteristics Of Gsk2269557, An Inhaled Pi3kä Inhibitor Under Development For The Treatment Of COPD
Hessel, E M, Hamblin, J N, Begg, M, Wilson, R, Dunsire, L, Sriskantharajah, S, Montembault, M, Leemereise, C, Galinanes-Garcia, L, Watz, H, Kirsten, A, Fuhr, R, Cahn, A
Published in American journal of respiratory and critical care medicine (01.01.2017)
Get full text
Published in American journal of respiratory and critical care medicine (01.01.2017)
Journal Article
Transforming activity of Fbxo7 is mediated specifically through regulation of cyclin D/cdk6
Laman, Heike, Funes, Juan M, Ye, Hongtao, Henderson, Stephen, Galinanes-Garcia, Laura, Hara, Eiji, Knowles, Phillip, McDonald, Neil, Boshoff, Chris
Published in The EMBO journal (07.09.2005)
Published in The EMBO journal (07.09.2005)
Get full text
Journal Article
Peptide-based, irreversible inhibitors of γ-secretase activity
Piper, Siân C., Amtul, Zareen, Galiñanes-Garcia, Laura, Howard, Victor G., Ziani-Cherif, Chewki, McLendon, Chris, Rochette, Marjorie J., Fauq, Abdul, Golde, Todd E., Paul Murphy, M.
Published in Biochemical and biophysical research communications (06.06.2003)
Published in Biochemical and biophysical research communications (06.06.2003)
Get full text
Journal Article